Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3093676
Max Phase: Preclinical
Molecular Formula: C13H19N3O2
Molecular Weight: 249.31
Molecule Type: Small molecule
Associated Items:
ID: ALA3093676
Max Phase: Preclinical
Molecular Formula: C13H19N3O2
Molecular Weight: 249.31
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1cc(CC(=O)N2C[C@@H]3CNC[C@@H](C3)C2)on1
Standard InChI: InChI=1S/C13H19N3O2/c1-9-2-12(18-15-9)4-13(17)16-7-10-3-11(8-16)6-14-5-10/h2,10-11,14H,3-8H2,1H3/t10-,11+
Standard InChI Key: HYMPREVQXXQOEJ-PHIMTYICSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 249.31 | Molecular Weight (Monoisotopic): 249.1477 | AlogP: 0.59 | #Rotatable Bonds: 2 |
Polar Surface Area: 58.37 | Molecular Species: BASE | HBA: 4 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 10.26 | CX LogP: -0.70 | CX LogD: -3.41 |
Aromatic Rings: 1 | Heavy Atoms: 18 | QED Weighted: 0.83 | Np Likeness Score: -1.12 |
1. Eibl C, Munoz L, Tomassoli I, Stokes C, Papke RL, Gündisch D.. (2013) The 3,7-diazabicyclo[3.3.1]nonane scaffold for subtype selective nicotinic acetylcholine receptor ligands. Part 2: carboxamide derivatives with different spacer motifs., 21 (23): [PMID:24145137] [10.1016/j.bmc.2013.09.060] |
Source(1):